AI Science Tracker
EN

Interdisciplinary Program, Bioengineering Major, Seoul National University

1 discovery from 2020

Discoveries

Functional fine-mapping of noncoding risk variants in amyotrophic lateral sclerosis utilizing convolutional neural network.

Source check: Source checked. Not independent scientific confirmation.

Finding: The analysis of 14,791 ALS cases and 26,898 controls across 41 strata nominated two variant/gene candidates with lymphoblastoid eQTL support. These are computational candidates, not demonstrated causal variants or mechanisms in ALS.

Technology: A convolutional neural network combined functional genomic annotations with eQTL evidence to prioritize noncoding ALS risk variants and candidate genes.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
A convolutional neural network combined functional genomic annotations with eQTL evidence to prioritize noncoding ALS risk variants and candidate genes.
Test and result
The analysis of 14,791 ALS cases and 26,898 controls across 41 strata nominated two variant/gene candidates with lymphoblastoid eQTL support.
Limitation / still unknown
These are computational candidates, not demonstrated causal variants or mechanisms in ALS.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-020-69790-6

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.